Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer’s Lyrica: DEA Proposes Schedule V Designation, Comments Due June 13

May 13 2005

• By John Rancourt

Related Content

Lyrica Scheduling Decision Expected In Second Quarter; Launch To Follow

Apr 05 2005

Pfizer Lyrica Undergoing Controlled Substance Scheduling At DEA

Jan 03 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window